1-161524971-G-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_002155.5(HSPA6):c.313G>T(p.Val105Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000184 in 1,613,446 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002155.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HSPA6 | NM_002155.5 | c.313G>T | p.Val105Leu | missense_variant | 1/1 | ENST00000309758.6 | NP_002146.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HSPA6 | ENST00000309758.6 | c.313G>T | p.Val105Leu | missense_variant | 1/1 | 6 | NM_002155.5 | ENSP00000310219.4 | ||
ENSG00000273112 | ENST00000537821.2 | n.271+6834G>T | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152104Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000100 AC: 25AN: 249896Hom.: 0 AF XY: 0.0000738 AC XY: 10AN XY: 135522
GnomAD4 exome AF: 0.000198 AC: 290AN: 1461342Hom.: 1 Cov.: 33 AF XY: 0.000193 AC XY: 140AN XY: 726990
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152104Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74304
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 14, 2023 | The c.313G>T (p.V105L) alteration is located in exon 1 (coding exon 1) of the HSPA6 gene. This alteration results from a G to T substitution at nucleotide position 313, causing the valine (V) at amino acid position 105 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at